← All stocks

Viking Therapeutics, Inc.

VKTX Net selling
CIK 0001607678 #1525 in the set updated 18 Sep 2026
Bought (120 mo)
$960.63K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$151.41M
$1.35M on a plan · $99.04M straight out of an exercise
Sold at will
$51.02M
44 of 111 sales
Net
−$150.45M
−$50.06M against sales at will

By person

14 insiders · 125 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lian Brian
President & CEO
$74.66M (36) scheduled
−$74.66M
2,572,441
2.21%
$86.09M
+72.0%
Mancini Marianna
Chief Operating Officer
$32.19M (19) scheduled
−$32.19M
422,760
0.3624%
$14.15M
+260.0%
ZANTE GREG
Chief Financial Officer
$26.05M (30) scheduled
−$26.05M
212,204
0.1819%
$7.10M
+335.2%
LIGAND PHARMACEUTICALS INC entity
10% owner
$6.36M (3)
−$6.36M
5,819,383
4.99%
$194.75M
−6.8%
SINGLETON J MATTHEW
Director
$93.26K (1)
$4.58M (11) scheduled
−$4.48M
12,650
0.0108%
$423.33K
Rowland Charles A Jr
Director
$154.80K (1)
$3.13M (2) scheduled
−$2.98M
33,150
0.0284%
$1.11M
Rouan Sarah Kathryn
Director
$29.94K (1)
$2.28M (3) scheduled
−$2.25M
4,390
0.0038%
$146.91K
MACARTNEY LAWSON
Director
$250.33K (1)
$1.29M (4) scheduled
−$1.04M
51,115
0.0438%
$1.71M
FOEHR MATTHEW W
Director
$240.67K (3)
$657.24K (2) scheduled
−$416.57K
135,186
0.1159%
$4.52M
+415.0%
MORNEAU MICHAEL
VP, Finance and Administration
$199.35K (1)
−$199.35K
116,062
0.0995%
$3.88M
−5.4%
Aubuchon Neil William
Chief Commercial Officer
$149.91K (1)
+$149.91K
4,475
0.0038%
$149.76K
Webster Stephen W
Director
$41.71K (1)
+$41.71K
8,000
0.0069%
$267.72K
Masamune Hiroko
Chief Development Officer
141,063
0.1209%
$4.72M
+36.4%
Kelly-Gemmell Dorothy Elizabeth
Director
6,333
0.0054%
$211.94K
Insider
Date
Role
Action
Shares
Price
Amount
FOEHR MATTHEW W
11 Apr 2025
Director
Exercised, kept
20,786
$8.00
$166.29K
Mancini Marianna
30 Mar 2023
Chief Operating Officer
Exercised, kept
3,000
$6.47
$19.41K
Mancini Marianna
30 Mar 2023
Chief Operating Officer
Exercised, kept
10,000
$7.69
$76.90K
Mancini Marianna
30 Mar 2023
Chief Operating Officer
Exercised, kept
23,100
$8.52
$196.81K
FOEHR MATTHEW W
22 Mar 2021
Director
Exercised, kept
20,000
$1.50
$30.00K

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 66
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 8,612,884
Sales filed before the plan box existed 5
History held since 15 Nov 2016